# Pemvidutide (ALT-801) in NASH mice: weight and liver results

Source: https://pepvault.app/research/pemvidutide-nestor-2022

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Pemvidutide](https://pepvault.app/research#pemvidutide)

Animal study · mice

# Pemvidutide cut body weight about 25% in mice with NASH

Checked against the paper November 2026 Animal study [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In a mouse model of NASH, pemvidutide beat semaglutide and elafibranor on weight and several liver measures, but this is early animal evidence, not a human result.

- **Kind:** Animal study
- **Studied in:** Mice
- **Published:** 2022
- **Journal:** Sci Rep

## What they tested

The team tested how pemvidutide (ALT-801) compared with semaglutide and elafibranor on weight and liver disease in a mouse model of NASH, a fatty liver disease with inflammation.

## How the study was done

A study in male C57BL/6J mice fed a NASH-inducing diet for 32 weeks, with liver fat and scarring confirmed by biopsy, a small tissue sample. They then got pemvidutide, semaglutide, elafibranor or vehicle (an inactive control) daily for 12 weeks while staying on the diet.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

In mice, pemvidutide reduced body weight by about 25%. It also lowered blood liver enzymes and blood total cholesterol, cut fat and cholesterol in the liver, and improved liver steatosis (fat buildup), with bigger drops than semaglutide or elafibranor (p < 0.05). It lowered galectin-3, an inflammation marker, and collagen type 1 alpha 1, a scarring marker, compared with vehicle (p < 0.05), and cut galectin-3 more than elafibranor (p < 0.05). Every mouse on pemvidutide improved its NAS, a combined score of fatty liver disease activity, compared with the active controls.

## What it doesn’t show

This was a mouse study, so it doesn't show the same effects in people. It used only male mice and lasted 12 weeks of treatment.

## The paper

Nestor et al. Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis. Sci Rep. 2022.

- [PubMed (PMID 35461369)](https://pubmed.ncbi.nlm.nih.gov/35461369/)
- [The paper (DOI 10.1038/s41598-022-10577-2)](https://doi.org/10.1038/s41598-022-10577-2)

## The compound

- [Pemvidutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)

## With this study

### Pemvidutide

- [Pemvidutide: the full reference](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pemvidutide-10mg)

### Studies

- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026)
- [Pemvidutide: up to 76.4% liver fat reduction at 24 weeks in MASLD](https://pepvault.app/research/pemvidutide-browne-2025)
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025)
- [All 4 studies](https://pepvault.app/research#pemvidutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

## More studies on Pemvidutide

- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026) Randomized trial · people · 2026
- [Pemvidutide: up to 76.4% liver fat reduction at 24 weeks in MASLD](https://pepvault.app/research/pemvidutide-browne-2025) Randomized trial · people · 2025
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025) Randomized trial · people · 2025
- [Every study on Pemvidutide](https://pepvault.app/research#pemvidutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Pemvidutide

- [Pemvidutide: the full reference](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pemvidutide-10mg)

### Studies

- [Pemvidutide: liver fat down 54.7% at 48 weeks in IMPACT MASH trial](https://pepvault.app/research/pemvidutide-impact-2026)
- [Pemvidutide: up to 76.4% liver fat reduction at 24 weeks in MASLD](https://pepvault.app/research/pemvidutide-browne-2025)
- [Pemvidutide: MASH resolved in up to 58% vs 20% on placebo at 24 weeks](https://pepvault.app/research/pemvidutide-impact-2025)
- [All 4 studies](https://pepvault.app/research#pemvidutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

<!--promo-->

PepVault for iPhone

## Taking pemvidutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Pemvidutide](https://pepvault.app/research#pemvidutide)

## The library

- [Pemvidutide](https://pepvault.app/peptides/pemvidutide)
- [Pemvidutide dose guide](https://pepvault.app/lab/dosage/pemvidutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
